Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayatri Rao

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type ICristina Mesa-Núñez, Carlos Damián, María Fernández-García, et al.
American Journal of Hematology|May 13, 2021
Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patientsMaría José Ramírez, Roser Pujol, Juan Pablo Trujillo-Quintero, et al.
Lancet (London, England)|December 6, 2024
Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trialsPaula Río, Josune Zubicaray, Susana Navarro, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type ICristina Mesa-Núñez, Carlos Damián, María Fernández-García, et al.
American Journal of Hematology|May 13, 2021
Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patientsMaría José Ramírez, Roser Pujol, Juan Pablo Trujillo-Quintero, et al.
Lancet (London, England)|December 6, 2024
Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trialsPaula Río, Josune Zubicaray, Susana Navarro, et al.
Pageof 2